| Product Code: ETC12954031 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Multiple System Atrophy Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Multiple System Atrophy Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Multiple System Atrophy Market - Industry Life Cycle |
3.4 Israel Multiple System Atrophy Market - Porter's Five Forces |
3.5 Israel Multiple System Atrophy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Multiple System Atrophy Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Israel Multiple System Atrophy Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Israel Multiple System Atrophy Market Revenues & Volume Share, By Symptom Management, 2021 & 2031F |
3.9 Israel Multiple System Atrophy Market Revenues & Volume Share, By Stage, 2021 & 2031F |
4 Israel Multiple System Atrophy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of multiple system atrophy (MSA) in Israel |
4.2.2 Technological advancements in treatment options for MSA |
4.2.3 Growing geriatric population in Israel leading to higher prevalence of MSA |
4.3 Market Restraints |
4.3.1 Limited treatment options available for MSA in Israel |
4.3.2 High cost associated with MSA treatment and management |
4.3.3 Lack of specialized healthcare professionals for MSA in Israel |
5 Israel Multiple System Atrophy Market Trends |
6 Israel Multiple System Atrophy Market, By Types |
6.1 Israel Multiple System Atrophy Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Multiple System Atrophy Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Multiple System Atrophy Market Revenues & Volume, By MSA-P (Parkinsonian), 2021 - 2031F |
6.1.4 Israel Multiple System Atrophy Market Revenues & Volume, By MSA-C (Cerebellar), 2021 - 2031F |
6.1.5 Israel Multiple System Atrophy Market Revenues & Volume, By Combined MSA, 2021 - 2031F |
6.1.6 Israel Multiple System Atrophy Market Revenues & Volume, By Autonomic Failure, 2021 - 2031F |
6.1.7 Israel Multiple System Atrophy Market Revenues & Volume, By Genetic Predisposition, 2021 - 2031F |
6.2 Israel Multiple System Atrophy Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Israel Multiple System Atrophy Market Revenues & Volume, By MRI, 2021 - 2031F |
6.2.3 Israel Multiple System Atrophy Market Revenues & Volume, By CT Scan, 2021 - 2031F |
6.2.4 Israel Multiple System Atrophy Market Revenues & Volume, By Blood Tests, 2021 - 2031F |
6.2.5 Israel Multiple System Atrophy Market Revenues & Volume, By Neurological Exam, 2021 - 2031F |
6.2.6 Israel Multiple System Atrophy Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.3 Israel Multiple System Atrophy Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Israel Multiple System Atrophy Market Revenues & Volume, By Medications, 2021 - 2031F |
6.3.3 Israel Multiple System Atrophy Market Revenues & Volume, By Physical Therapy, 2021 - 2031F |
6.3.4 Israel Multiple System Atrophy Market Revenues & Volume, By Occupational Therapy, 2021 - 2031F |
6.3.5 Israel Multiple System Atrophy Market Revenues & Volume, By Assistive Devices, 2021 - 2031F |
6.3.6 Israel Multiple System Atrophy Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.4 Israel Multiple System Atrophy Market, By Symptom Management |
6.4.1 Overview and Analysis |
6.4.2 Israel Multiple System Atrophy Market Revenues & Volume, By Motor Control, 2021 - 2031F |
6.4.3 Israel Multiple System Atrophy Market Revenues & Volume, By Speech Therapy, 2021 - 2031F |
6.4.4 Israel Multiple System Atrophy Market Revenues & Volume, By Bladder Management, 2021 - 2031F |
6.4.5 Israel Multiple System Atrophy Market Revenues & Volume, By Orthostatic Hypotension, 2021 - 2031F |
6.4.6 Israel Multiple System Atrophy Market Revenues & Volume, By Swallowing Difficulties, 2021 - 2031F |
6.5 Israel Multiple System Atrophy Market, By Stage |
6.5.1 Overview and Analysis |
6.5.2 Israel Multiple System Atrophy Market Revenues & Volume, By Early Stage, 2021 - 2031F |
6.5.3 Israel Multiple System Atrophy Market Revenues & Volume, By Progressive Stage, 2021 - 2031F |
6.5.4 Israel Multiple System Atrophy Market Revenues & Volume, By Advanced Stage, 2021 - 2031F |
6.5.5 Israel Multiple System Atrophy Market Revenues & Volume, By Late Stage, 2021 - 2031F |
6.5.6 Israel Multiple System Atrophy Market Revenues & Volume, By Palliative Stage, 2021 - 2031F |
7 Israel Multiple System Atrophy Market Import-Export Trade Statistics |
7.1 Israel Multiple System Atrophy Market Export to Major Countries |
7.2 Israel Multiple System Atrophy Market Imports from Major Countries |
8 Israel Multiple System Atrophy Market Key Performance Indicators |
8.1 Average age of MSA diagnosis in Israel |
8.2 Number of clinical trials for MSA treatments in Israel |
8.3 Adoption rate of new MSA treatment technologies |
8.4 Percentage of MSA patients receiving timely and appropriate care |
8.5 Patient satisfaction levels with MSA care and support services |
9 Israel Multiple System Atrophy Market - Opportunity Assessment |
9.1 Israel Multiple System Atrophy Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Multiple System Atrophy Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Israel Multiple System Atrophy Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Israel Multiple System Atrophy Market Opportunity Assessment, By Symptom Management, 2021 & 2031F |
9.5 Israel Multiple System Atrophy Market Opportunity Assessment, By Stage, 2021 & 2031F |
10 Israel Multiple System Atrophy Market - Competitive Landscape |
10.1 Israel Multiple System Atrophy Market Revenue Share, By Companies, 2024 |
10.2 Israel Multiple System Atrophy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here